Author： Kennedy William Klugh Leloux Megan Kutscher Eric C Price Paul L Morstad Anne E Carnahan Ryan M
Publisher： Informa Healthcare
ISSN： 1742-5255
Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.6, Iss.3, 2010-03, pp. : 363-380
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Drugs in R&D, Vol. 3, Iss. 1, 2002-01 ,pp. :
Access to resources
Recommend
Acamprosate: Pharmacoeconomic Implications of Therapy
PharmacoEconomics, Vol. 16, Iss. 6, 1999-12 ,pp. :
Clinical Pharmacokinetics of Acamprosate
By Saivin S.
Clinical Pharmacokinetics, Vol. 35, Iss. 5, 1998-11 ,pp. :
Acamprosate, naltrexone underused in Australia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 428, 2003-01 ,pp. :
Acamprosate in the treatment of alcohol dependence
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. :